Justin Cowan, PhD

Treatment of Fragile X Syndrome via Dopamine Enhancers and Glutamate Inhibitors

In Fragile X mice, low dopamine signaling and excessive glutamate activity were targeted with dual therapy: dopamine enhancers plus glutamate inhibitors.

Read More »

Categories

FRAXA Funded Research

Current Research Grants (38)